A new study from JAMA Psychiatry reveals a significant association between chronic cannabis use and ..
..Read More
The “anti-diet” trend has grown in popularity online, encouraging people to stop dieting..
..Read More
With over 233,000 cases this season, Argentina faces a dire shortage of bug spray as Latin America f..
..Read More
Ready-to-eat packed food Lunchables contains a lot of sodium, finds advocacy group Consumer Reports ..
..Read More
Weight loss GLP-1 drugs like Ozempic, Wegovy, Mounjaro and Zepbound have gained popularity over the ..
..Read More
A recent study indicates that the popular diabetes and weight loss drug Ozempic could be produced fo..
..Read More
The Supreme Court will hear oral arguments in the FDA v. Alliance for Hippocratic Medicine, a case c..
..Read More
The United States has slipped out of the top 20 happiest nations, marking its first absence since th..
..Read More
Between 2020 and 2023, yearly abortions rose by 10% in the US, with medicated abortions becoming mor..
..Read More
A recent report from the Pew Research Center reveals that nearly 40% of US teenagers have reduced th..
..Read More
Companies across the nation are reassessing their employee healthcare reimbursement plans as the cos..
..Read More
Need a quick doctor’s note or refill approval? Brace yourself for potential costs. Physicians ..
..Read More
Two of the largest pharmacy chains in the country, CVS and Walgreens, will begin selling common abor..
..Read More
Iconic talk show host Oprah Winfrey is leaving the board of WeightWatchers (WW), which she joined in..
..Read More
Alabama’s largest hospital, the University of Alabama at Birmingham Health System, has halted ..
..Read More
The FDA recently approved asthma medication, omalizumab (brand name Xolair), to reduce allergic reac..
..Read More
The Federal Trade Commission (FTC) has launched an investigation into recent shortages of carboplati..
..Read More
In a startling revelation, a massive Medicare fraud scheme—estimated at a staggering $2 billio..
..Read More
An experimental drug that could alleviate moderate to severe pain, without the risk of addiction tha..
..Read More
Senate Majority Leader Chuck Schumer has called for investigations by the Federal Trade Commission a..
..Read More
Johnson & Johnson (J&J) has tentatively agreed to pay approximately $700 million to settle a..
..Read More
Cameroon initiated the world’s first routine vaccine program against malaria yesterday, markin..
..Read More
The demand for ADHD treatments spiked among adults during the COVID-19 pandemic, exacerbating shorta....
..Read More
Columbia and Rutgers University researchers have uncovered a startling revelation about bottled wate..
..Read More
The Food and Drug Administration (FDA) yesterday approved Florida's request to import prescripti..
..Read More
New research reveals that thousands of American women stocked up on abortion pills, especially durin..
..Read More
The Food and Drug Administration (FDA) issued a warning about a deadly bacterial contamination in Re..
..Read More
Over 40 million women annually face enduring health issues post-childbirth, a new study in The Lance..
..Read More
An organization is seeking the US Food and Drug Administration (FDA) approval for the use of the psy..
..Read More
The Food and Drug Administration (FDA) has approved Casgevy, the first gene-editing therapy ever to ..
..Read More
No fillers. No hidden agenda. News as it should be.
Daily Shorts is a fresh media company that focuses on you. Our goal is to empower you with unbiased and easy-to-digest information to help you grow and understand the world better.
We believe reading news is a lost art. Clickbait journalism and loud media narratives are constantly telling you what to think. At Daily Shorts, you will only find the news most relevant to you.
We are fuelled by curiosity and dedicated to writing stories that would excite and move every reader. Fulfilling these promises requires Daily Shorts to reach every person’s inbox. And this is why we decided not to charge you for subscription.
We are free and will always be because we believe that quality journalism is not a luxury or exclusive to a few, but everyone’s right.
We make news reading fun.
This website uses cookies or similar technologies, to enhance your browsing experience and provide personalized recommendations. By continuing to use our website, you agree to our Privacy Policy